Voyager Therapeutics (VYGR) Return on Invested Capital (2017 - 2025)
Historic Return on Invested Capital for Voyager Therapeutics (VYGR) over the last 5 years, with Q3 2025 value amounting to 0.61%.
- Voyager Therapeutics' Return on Invested Capital fell 6300.0% to 0.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61%, marking a year-over-year decrease of 6300.0%. This contributed to the annual value of 0.31% for FY2024, which is 11300.0% down from last year.
- Latest data reveals that Voyager Therapeutics reported Return on Invested Capital of 0.61% as of Q3 2025, which was down 6300.0% from 0.48% recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Return on Invested Capital registered a high of 0.67% during Q1 2023, and its lowest value of 0.61% during Q3 2025.
- Over the past 3 years, Voyager Therapeutics' median Return on Invested Capital value was 0.02% (recorded in 2024), while the average stood at 0.01%.
- Examining YoY changes over the last 5 years, Voyager Therapeutics' Return on Invested Capital showed a top increase of -2000bps in 2024 and a maximum decrease of -8500bps in 2024.
- Voyager Therapeutics' Return on Invested Capital (Quarter) stood at 0.59% in 2023, then plummeted by -146bps to 0.27% in 2024, then plummeted by -128bps to 0.61% in 2025.
- Its last three reported values are 0.61% in Q3 2025, 0.48% for Q2 2025, and 0.36% during Q1 2025.